BNP Paribas Financial Markets’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-9,972
Closed -$179K 3673
2020
Q2
$179K Sell
9,972
-35,143
-78% -$632K ﹤0.01% 1936
2020
Q1
$322K Buy
45,115
+27,829
+161% +$198K ﹤0.01% 2033
2019
Q4
$413K Buy
17,286
+1,843
+12% +$44K ﹤0.01% 1953
2019
Q3
$414K Buy
15,443
+3,027
+24% +$81.2K ﹤0.01% 1730
2019
Q2
$337K Sell
12,416
-2,624
-17% -$71.2K ﹤0.01% 1679
2019
Q1
$522K Buy
15,040
+11,736
+355% +$407K ﹤0.01% 1552
2018
Q4
$64.5K Sell
3,304
-1,719
-34% -$33.6K ﹤0.01% 1934
2018
Q3
$134K Sell
5,023
-152,173
-97% -$4.05M ﹤0.01% 1949
2018
Q2
$5.94M Buy
157,196
+145,094
+1,199% +$5.48M 0.01% 690
2018
Q1
$395K Buy
12,102
+33
+0.3% +$1.08K ﹤0.01% 1835
2017
Q4
$588K Buy
12,069
+5,191
+75% +$253K ﹤0.01% 1763
2017
Q3
$372K Buy
6,878
+469
+7% +$25.3K ﹤0.01% 1892
2017
Q2
$360K Buy
6,409
+5,278
+467% +$296K ﹤0.01% 1822
2017
Q1
$44.3K Sell
1,131
-665
-37% -$26.1K ﹤0.01% 2338
2016
Q4
$40.3K Sell
1,796
-2,350
-57% -$52.7K ﹤0.01% 2472
2016
Q3
$94.2K Buy
4,146
+2,192
+112% +$49.8K ﹤0.01% 2131
2016
Q2
$46.1K Buy
1,954
+1,914
+4,785% +$45.2K ﹤0.01% 2324
2016
Q1
$816 Sell
40
-76,812
-100% -$1.57M ﹤0.01% 2525
2015
Q4
$3.95M Buy
76,852
+34,140
+80% +$1.76M 0.01% 712
2015
Q3
$1.82M Buy
42,712
+5,568
+15% +$237K ﹤0.01% 879
2015
Q2
$1.69M Buy
37,144
+36,125
+3,545% +$1.65M ﹤0.01% 932
2015
Q1
$38.7K Buy
+1,019
New +$38.7K ﹤0.01% 2048
2014
Q4
Sell
-2,189
Closed -$55.3K 3072
2014
Q3
$55.3K Buy
2,189
+2,130
+3,610% +$53.8K ﹤0.01% 2118
2014
Q2
$1.72K Buy
+59
New +$1.72K ﹤0.01% 2716
2014
Q1
Sell
-141
Closed -$3.63K 3368
2013
Q4
$3.63K Buy
+141
New +$3.63K ﹤0.01% 2801